Back

Impact of cardiac resynchronisation therapy in patients with cardiac sarcoidosis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Heart failure: let’s re-synchronise please Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Raheel Ahmed

Freeman Hospital, Newcastle-Upon-Tyne (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Cardiac resynchronisation therapy and implantable cardioverter-defibrillator in non-ischaemic systolic heart failure: extended follow-up of the DANISH trial
Doctor A. Yafasova (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Cardiac resynchronization therapy: association between genetically determinated dilated cardiomyopathy and dissinchronopathy
Doctor M. Zecchin (Trieste, IT)
Abstract Slides Video
Presentation thumbnail
The impact of right ventricular size and function on long-term outcomes in patients undergoing cardiac resynchronization therapy
Mr X. Galloo (Brussels, BE)
Abstract Slides Video
Presentation thumbnail
Biventricular or left univentricular pacing in heart failure patients: is there a better strategy
Doctor M. Barradas (Ponta Delgada, PT)
Abstract Slides Video
Presentation thumbnail
Prediction of response to cardiac resynchronization therapy using cardiac magnetic resonance imaging in non-ischemic dilated cardiomyopathy
Doctor S. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: let’s re-synchronise please

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchronization therapy with left bundle branch area pacing in patients with a definitive diagnosis of cardiac sarcoidosis
thumbnail
Congress Presentation
Cardiac sarcoidosis
thumbnail
Congress Presentation
Challenges in diagnosing and managing cardiac sarcoidosis: ventricular tachycardia in a patient with non-dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources